1. Wetzel B, Hauel N (1988) New cardiotonic agents—a promising approach for treatment of heart failure. Trends Pharmacol Sci 9: 166–170
2. Endoh M, Yanagisawa T, Taira N, Blinks JR (1986) Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle. Circulation 73 (Suppl III): 117–133
3. Kitada Y, Narimatsu A, Matsumura N, Endo M (1987) Increase in Ca++ sensitivity of the contractile system by MCI-154, a novel cardiotonic agent, in chemically skinned fibers from the guinea pig papillary muscles. J Pharmacol Exp Ther 243: 633–638
4. Taira N (1984) New positive inotropic agents: their modes and mechanisms of action. In: Abe H et al. (eds) Regulation of cardiac function. Japan Sci Soc Press, Tokyo, pp 293–303
5. Yamashita S, Hosokawa T, Kojima M, Mori T, Yabuuchi Y (1984) In vitro and in vivo studies of 3,4-dihydro-6-[4-(3, 4-dimethoxybenzoyl)-1-piperazinyl]-2 (1H)-quinolinone (OPC-8212), a novel positive inotropic drug, in various animals. Arzneimittel Forschung 34: 342–346